Brokers Issue Forecasts for Krystal Biotech FY2026 Earnings
Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) – Investment analysts at Chardan Capital issued their FY2026 EPS estimates for Krystal Biotech in a research note issued to investors on Thursday, February 20th. Chardan Capital analyst Y. Livshits expects that the company will post earnings of $9.95 per share for the year. Chardan Capital currently has […]
